Quantification of hormone-induced atrophy of large myotubes from C2C12and L6 cells: atrophy-inducible and atrophy-resistant C2C12myotubes
- 1 February 2006
- journal article
- Published by American Physiological Society in American Journal of Physiology-Cell Physiology
- Vol. 290 (2), C650-C659
- https://doi.org/10.1152/ajpcell.00163.2005
Abstract
Myofiber atrophy is the final outcome of muscle wasting induced by catabolic factors such as glucocorticoids and thyroid hormones. We set up an in vitro system to define the catabolic reaction based on myotube atrophy. Both mouse C2C12and rat L6 cells were used. C2C12myotube formation was improved by replacing horse serum with the serum substitute Ultroser G. A new method was developed to quantify size changes of large (0.5–1 mm) myotubes only, excluding remaining myoblasts and small myotubes. Dexamethasone reduced myotube size by 30% in L6 but not in C2C12myotubes. Expression of the glucocorticoid receptor was twofold higher in L6 myotubes than in C2C12myotubes. In both cell lines, 3,3′,5-triiodo-l-thyronine (T3) did not induce a significant size reduction. Expression of the major T3receptor (T3Rβ1) was higher in L6 myotubes. We investigated whether the changes in myotube size are related to changes in atrogin-1 expression, as this enzyme is thought to be a key factor in the initiation of muscle atrophy. Dexamethasone induced a twofold increase of atrogin-1 mRNA; again, only L6 myotubes were susceptible. Interestingly, atrogin-1 expression in Ultroser G-fused C2C12myotubes was lower than that in horse serum-fused myotubes. Furthermore, dexamethasone treatment increased atrogin-1 expression only in horse serum-fused myotubes but not in Ultroser G-fused myotubes. Ultroser G-induced fusion may result in atrophy-resistant C2C12myotubes. Therefore, C2C12myotubes offer an ideal system in which to study skeletal muscle atrophy because, depending on differentiation conditions, C2C12cells produce atrophy-inducible and atrophy-resistant myotubes.Keywords
This publication has 39 references indexed in Scilit:
- IGF-I stimulates muscle growth by suppressing protein breakdown and expression of atrophy-related ubiquitin ligases, atrogin-1 and MuRF1American Journal of Physiology-Endocrinology and Metabolism, 2004
- The IGF-1/PI3K/Akt Pathway Prevents Expression of Muscle Atrophy-Induced Ubiquitin Ligases by Inhibiting FOXO Transcription FactorsMolecular Cell, 2004
- Effect of glycogen synthase overexpression on insulin-stimulated muscle glucose uptake and storageAmerican Journal of Physiology-Endocrinology and Metabolism, 2004
- In Vivo Regulation of Human Skeletal Muscle Gene Expression by Thyroid HormoneGenome Research, 2002
- HORMONAL REGULATION OF HUMAN MUSCLE PROTEIN METABOLISMAnnual Review of Nutrition, 1997
- The biochemical and structural maturation of human skeletal muscle cells in culture: The effect of the serum substitute Ultroser G*1Experimental Cell Research, 1991
- Nuclear glucocorticoid receptor binding in L6 skeletal muscle cells in cultureJournal of Steroid Biochemistry, 1988
- Skeletal muscle and whole body protein turnover in thyroid diseaseEuropean Journal of Clinical Investigation, 1988
- L6 cells as a tissue culture model for thyroid hormone effects on skeletal muscle metabolism.JCI Insight, 1985
- Serial passaging and differentiation of myogenic cells isolated from dystrophic mouse muscleNature, 1977